-
1.
公开(公告)号:US20090169546A1
公开(公告)日:2009-07-02
申请号:US12094447
申请日:2006-11-27
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
IPC分类号: A61K39/395 , C07K16/00 , G01N33/53 , C12Q1/68 , A61P37/06
CPC分类号: C07K16/24 , A61K2039/505 , C07K2317/21 , C07K2317/55 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/32
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn s disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤, 败血症,内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
公开(公告)号:US08129130B2
公开(公告)日:2012-03-06
申请号:US13051327
申请日:2011-03-18
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
IPC分类号: G01N33/53
CPC分类号: C07K16/24 , A61K38/1709 , A61K39/39 , A61K2039/505 , C07K2317/21 , C07K2317/76 , C07K2317/92 , C07K2317/94 , A61K2300/00
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
-
3.
公开(公告)号:US20110287023A1
公开(公告)日:2011-11-24
申请号:US13051327
申请日:2011-03-18
申请人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
发明人: Herren Wu , Changshou Gao , Ling-Ling An , Peter Kiener , Su-Yau Mao , Anthony Coyle , Jane Tian , Theresa O'Keefe , Shixin Qin
CPC分类号: C07K16/24 , A61K38/1709 , A61K39/39 , A61K2039/505 , C07K2317/21 , C07K2317/76 , C07K2317/92 , C07K2317/94 , A61K2300/00
摘要: Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.
摘要翻译: 公开了用于抑制促炎细胞因子从脊椎动物细胞中释放并抑制患者炎性细胞因子级联的组合物和方法。 组合物包含例如特异性结合HMG1的高亲和力抗体及其抗原性片段。 本发明的高亲和力抗体和包含其的药物组合物可用于许多目的,例如作为针对广泛范围的炎性疾病和病症的治疗剂,例如败血症,类风湿性关节炎,腹膜炎,克罗恩病,再灌注损伤,败血症 内毒素性休克,囊性纤维化,心内膜炎,牛皮癣,牛皮癣关节炎,关节炎,过敏性休克,器官缺血,再灌注损伤和同种异体移植排斥。 此外,本发明的高亲和力抗体可用作诊断抗体。
-
4.
公开(公告)号:US20140322233A1
公开(公告)日:2014-10-30
申请号:US14293802
申请日:2014-06-02
IPC分类号: C07K16/40 , G01N33/573 , A61K39/395 , A61K47/48
摘要: Antibodies and antigen-binding fragments of antibodies that bind GCC are disclosed. The antibodies bind an extracellular domain of GCC and can be internalized. In some embodiments, the antibodies are humanized, chimeric or human. Nucleic acids and vectors encoding the antibodies or portions thereof, recombinant cells that contain the nucleic acids, and compositions comprising the antibodies or antigen-binding fragments are also disclosed. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
摘要翻译: 公开了结合GCC的抗体和抗原结合片段。 抗体结合GCC的细胞外结构域并可以内化。 在一些实施方案中,抗体是人源化的,嵌合的或人的。 还公开了编码抗体或其部分的核酸和载体,含有核酸的重组细胞,以及包含抗体或抗原结合片段的组合物。 本发明还提供了利用本文提供的抗体和抗原结合片段的治疗和诊断方法。
-
公开(公告)号:US20060057679A1
公开(公告)日:2006-03-16
申请号:US11186422
申请日:2005-07-20
申请人: Theresa O'Keefe , Peter Luciano , Shixin Qin
发明人: Theresa O'Keefe , Peter Luciano , Shixin Qin
IPC分类号: C07K16/46 , C07K14/705 , C07H21/04 , C12P21/04 , C12N5/06
CPC分类号: C07K14/70503 , A61K38/00 , C07K14/705 , C07K2319/30 , C07K2319/32
摘要: The present invention is drawn to fusion proteins comprising a Receptor for Advanced Glycation Endproducts (RAGE) and an immunoglobulin element. The invention also encompasses methods of treating a condition characterized by activation of an inflammatory cytokine cascade comprising administering such fusion proteins. The invention is also drawn to nucleic acids encoding the fusion proteins, as well as vectors and cells comprising such nucleic acids.
摘要翻译: 本发明涉及包含高级糖基化终产物(RAGE)受体和免疫球蛋白元件的融合蛋白。 本发明还包括治疗特征为激活炎性细胞因子级联的病症的方法,包括施用这种融合蛋白。 本发明还涉及编码融合蛋白的核酸,以及包含这种核酸的载体和细胞。
-
公开(公告)号:US07470521B2
公开(公告)日:2008-12-30
申请号:US11186422
申请日:2005-07-20
申请人: Theresa O'Keefe , Peter Luciano , Shixin Qin
发明人: Theresa O'Keefe , Peter Luciano , Shixin Qin
CPC分类号: C07K14/70503 , A61K38/00 , C07K14/705 , C07K2319/30 , C07K2319/32
摘要: The present invention is drawn to fusion proteins comprising a Receptor for Advanced Glycation Endproducts (RAGE) and an immunoglobulin element. The invention also encompasses methods of treating a condition characterized by activation of an inflammatory cytokine cascade comprising administering such fusion proteins. The invention is also drawn to nucleic acids encoding the fusion proteins, as well as vectors and cells comprising such nucleic acids.
摘要翻译: 本发明涉及包含高级糖基化终产物(RAGE)受体和免疫球蛋白元件的融合蛋白。 本发明还包括治疗特征为激活炎性细胞因子级联的病症的方法,包括施用这种融合蛋白。 本发明还涉及编码融合蛋白的核酸,以及包含这种核酸的载体和细胞。
-
公开(公告)号:US20090202542A1
公开(公告)日:2009-08-13
申请号:US12313504
申请日:2008-11-19
申请人: Theresa O'Keefe , Peter Luciano , Shixin Qin
发明人: Theresa O'Keefe , Peter Luciano , Shixin Qin
IPC分类号: A61K39/395 , A61K38/16
CPC分类号: C07K14/70503 , A61K38/00 , C07K14/705 , C07K2319/30 , C07K2319/32
摘要: The present invention is drawn to fusion proteins comprising a Receptor for Advanced Glycation Endproducts (RAGE) and an immunoglobulin element. The invention also encompasses methods of treating a condition characterized by activation of an inflammatory cytokine cascade comprising administering such fusion proteins. The invention is also drawn to nucleic acids encoding the fusion proteins, as well as vectors and cells comprising such nucleic acids.
摘要翻译: 本发明涉及包含高级糖基化终产物(RAGE)受体和免疫球蛋白元件的融合蛋白。 本发明还包括治疗特征为激活炎性细胞因子级联的病症的方法,包括施用这种融合蛋白。 本发明还涉及编码融合蛋白的核酸,以及包含这种核酸的载体和细胞。
-
公开(公告)号:US20050152903A1
公开(公告)日:2005-07-14
申请号:US10938992
申请日:2004-09-10
申请人: Walter Newman , Shixin Qin , Theresa O'Keefe , Robert Obar
发明人: Walter Newman , Shixin Qin , Theresa O'Keefe , Robert Obar
IPC分类号: C07K14/47 , C07K16/18 , C12N5/20 , A61K39/395 , C07K16/24
CPC分类号: C07K14/4718 , A61K2039/505 , C07K16/24 , C07K2317/34 , C07K2317/565 , C07K2317/76 , Y10S435/81
摘要: In various embodiments, the present invention is drawn to antibodies or antigen-binding fragments thereof that bind to a vertebrate high mobility group box (HMGB) polypeptide, methods of detecting and/or identifying an agent that binds to an HMGB polypeptide, methods of treating a condition in a subject characterized by activation of an inflammatory cytokine cascade and methods of detecting an HMGB polypeptide in a sample.
摘要翻译: 在各种实施方案中,本发明涉及结合脊椎动物高迁移率组盒(HMGB)多肽的抗体或其抗原结合片段,检测和/或鉴定与HMGB多肽结合的试剂的方法,治疗方法 特征在于激活炎性细胞因子级联的受试者的病症以及检测样品中的HMGB多肽的方法。
-
公开(公告)号:US20130071381A1
公开(公告)日:2013-03-21
申请号:US13528407
申请日:2012-06-20
申请人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
发明人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
IPC分类号: C07K16/28
CPC分类号: C07K16/2866 , A61K2039/505 , C07K14/7158 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/567 , C07K2317/76 , C07K2319/00
摘要: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
-
公开(公告)号:US20080241136A1
公开(公告)日:2008-10-02
申请号:US11924794
申请日:2007-10-26
申请人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
发明人: Gregory J. LaRosa , Christopher J. Horvath , Walter Newman , S. Tarran Jones , Siobhan H. O'Brien , Theresa O'Keefe
IPC分类号: A61K39/395
CPC分类号: C07K16/2866 , A61K2039/505 , C07K2317/76
摘要: The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the interaction of a cell bearing mammalian CCR2 with a ligand thereof, and to use of the antibodies and fragments in therapeutic, prophylactic and diagnostic methods.
-
-
-
-
-
-
-
-
-